Current Report Filing (8-k)
June 16 2017 - 4:10PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE
ACT OF 1934
Date of Report (Date of Earliest Event Reported):
June 14,
2017
BIOSPECIFICS TECHNOLOGIES CORP.
(Exact name of registrant as specified in its charter)
Delaware
|
001-34236
|
11-3054851
|
(State or Other Jurisdiction
|
(Commission File Number)
|
(I.R.S. Employer
|
Of Incorporation)
|
|
Identification No.)
|
35 Wilbur Street
Lynbrook, NY 11563
(Address of Principal Executive Office) (Zip Code)
516.593.7000
(Registrants telephone number,
including area code)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e -4(c))
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 or Rule
12b-2 of the Securities Exchange Act of 1934.
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act. [ ]
INTRODUCTORY COMMENT
Throughout this Current Report
on Form 8-K, the terms we, us, our and Company refer to BioSpecifics
Technologies Corp.
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY
HOLDERS
The 2017 annual meeting of
stockholders of the Company (the 2017 Annual Meeting) was held on June 14,
2017. At the 2017 Annual Meeting, the holders of 6,736,339 shares of the
Companys common stock were represented in person or by proxy, thereby
constituting a quorum.
Set forth below are the final
voting results for each of the matters submitted to a vote of the stockholders
of the Company at the 2017 Annual Meeting.
Proposal 1.
The
stockholders of the Company elected Dr. Mark Wegman, Toby Wegman and Jennifer
Chao to the Board of Directors, each to serve until the 2020 annual meeting of
stockholders or until such person resigns, is removed, or otherwise leaves
office. The votes were cast as follows:
Director Name
|
For
|
Withheld
|
Dr. Mark Wegman
|
3,392,873
|
2,466,556
|
Toby Wegman
|
3,620,551
|
2,338,878
|
Jennifer Chao
|
3,462,959
|
2,396,470
|
Proposal 2.
The
stockholders of the Company approved, on an advisory basis, the Companys named
executive officer compensation as disclosed in the Companys proxy statement
filed with the Securities and Exchange Commission on April 28, 2017.
For
|
Against
|
Abstain
|
5,052,579
|
799,451
|
7,399
|
Proposal 3.
The
stockholders of the Company approved, on an advisory basis, one-year intervals
for the frequency of future advisory votes on the compensation of the Companys
named executive officer.
One-Year
|
Two-Year
|
Three-Year
|
Abstain
|
4,216,114
|
67,039
|
616,063
|
960,213
|
Proposal 4.
The
stockholders of the Company approved the ratification of the appointment of
EisnerAmper LLP as the Companys independent registered public accounting firm
for the fiscal year ending December 31, 2017. The votes were cast as follows:
For
|
Against
|
Abstain
|
6,501,487
|
228,281
|
6,571
|
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 16, 2017
|
BIOSPECIFICS TECHNOLOGIES CORP.
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
/s/Thomas L. Wegman
|
|
Thomas L. Wegman
|
|
President
|
BioSpecifics Technologies (NASDAQ:BSTC)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioSpecifics Technologies (NASDAQ:BSTC)
Historical Stock Chart
From Apr 2023 to Apr 2024